Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
10537062 | Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics | 2015 | 10 Pages |
Abstract
Protein biomarker development is a multidisciplinary task involving basic, translational and clinical research. Integration of multidisciplinary efforts in a single pipeline is challenging, but crucial to facilitate rational discovery of protein biomarkers and alleviate existing disappointments in the field. In this review, we discuss in detail individual phases of biomarker development pipeline, such as biomarker candidate identification, verification and validation. We focus on mass spectrometry as a principal technique for protein identification and quantification, and discuss complementary -omics approaches for selection of biomarker candidates. Proteomic samples, protein-based clinical laboratory tests and limitations of biomarker development are reviewed in detail, and critical assessment of all phases of biomarker development pipeline is provided. This article is part of a Special Issue entitled: Medical Proteomics.
Keywords
LOQAQUAITRAQFDAPSAQPSAQconCATSRMPTMLC–MS/MSm/zscxpost-translational modificationbiomarker validationisobaric tags for relative and absolute quantificationprotein biomarkerstrong cation exchangeEnzyme-linked immunosorbent assayELISASILACMass spectrometryLodlimit of quantificationlimit of detectionstable isotope labeling by amino acids in cell cultureselected reaction monitoringprostate-specific antigenProteomicsSingle nucleotide polymorphismSNPliquid chromatography–tandem mass spectrometryBiomarker discoveryAbsolute quantification
Related Topics
Physical Sciences and Engineering
Chemistry
Analytical Chemistry
Authors
Andrei P. Drabovich, Eduardo MartÃnez-Morillo, Eleftherios P. Diamandis,